全文获取类型
收费全文 | 1388615篇 |
免费 | 104172篇 |
国内免费 | 4441篇 |
专业分类
耳鼻咽喉 | 17543篇 |
儿科学 | 44708篇 |
妇产科学 | 37076篇 |
基础医学 | 204387篇 |
口腔科学 | 36810篇 |
临床医学 | 135305篇 |
内科学 | 269583篇 |
皮肤病学 | 27064篇 |
神经病学 | 117231篇 |
特种医学 | 49974篇 |
外国民族医学 | 371篇 |
外科学 | 193524篇 |
综合类 | 29397篇 |
现状与发展 | 1篇 |
一般理论 | 505篇 |
预防医学 | 118053篇 |
眼科学 | 30150篇 |
药学 | 102491篇 |
35篇 | |
中国医学 | 3263篇 |
肿瘤学 | 79757篇 |
出版年
2021年 | 12783篇 |
2019年 | 13134篇 |
2018年 | 18112篇 |
2017年 | 13509篇 |
2016年 | 14591篇 |
2015年 | 16728篇 |
2014年 | 22951篇 |
2013年 | 34767篇 |
2012年 | 48413篇 |
2011年 | 51199篇 |
2010年 | 29388篇 |
2009年 | 27106篇 |
2008年 | 46260篇 |
2007年 | 48649篇 |
2006年 | 48571篇 |
2005年 | 46888篇 |
2004年 | 44470篇 |
2003年 | 42271篇 |
2002年 | 40816篇 |
2001年 | 61190篇 |
2000年 | 62776篇 |
1999年 | 52607篇 |
1998年 | 15077篇 |
1997年 | 13680篇 |
1996年 | 13437篇 |
1995年 | 12743篇 |
1994年 | 11875篇 |
1993年 | 11154篇 |
1992年 | 41737篇 |
1991年 | 40889篇 |
1990年 | 39555篇 |
1989年 | 37437篇 |
1988年 | 34679篇 |
1987年 | 33776篇 |
1986年 | 32232篇 |
1985年 | 30706篇 |
1984年 | 23136篇 |
1983年 | 19668篇 |
1982年 | 11849篇 |
1979年 | 20843篇 |
1978年 | 14853篇 |
1977年 | 12106篇 |
1976年 | 11905篇 |
1975年 | 12134篇 |
1974年 | 14825篇 |
1973年 | 14491篇 |
1972年 | 13368篇 |
1971年 | 12425篇 |
1970年 | 11496篇 |
1969年 | 10417篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
41.
Anthony P. Adamis Christopher J. Brittain Atul Dandekar J. Jill Hopkins 《Eye (London, England)》2020,34(11):1966
This article aims to identify key opportunities for improvement in the diagnosis and treatment of retinal disease, and describe recent innovations that will potentially facilitate improved outcomes with existing intravitreal vascular endothelial growth factor (VEGF) therapies and lay the groundwork for new treatment approaches. The review begins with a summary of the key discoveries that led to the development of anti-VEGF therapies and briefly reviews their impact on clinical practice. Opportunities for improvements in diagnosis, real-world outcomes with existing therapies, long-acting therapeutics and personalised health care are discussed, as well as the need to identify new targets for therapeutic intervention. Low-cost, remote patient screening and monitoring using artificial intelligence (AI)-based technologies can help improve diagnosis rates and enable remote disease monitoring with minimal patient burden. AI-based tools can be applied to generate patient-level prognostic data and predict individual treatment needs, reducing the time needed to optimise a patient’s treatment regimen. Long-acting therapeutics can help improve visual outcomes by reducing the treatment burden. When paired with AI-generated prognoses, long-acting therapeutics enable the possibility of vision loss prevention. Dual-acting drugs may help improve efficacy and/or durability beyond what is possible with anti-VEGF agents alone. Recent developments and ongoing innovations will help build upon the success of anti-VEGF therapies to further reduce vision loss owing to retinal disease while lowering the overall burden of care.Subject terms: Retinal diseases, Quality of life 相似文献
42.
Laura L. Pitts Lynn Rogers Xue Wang Mariana M. Bahia Leora R. Cherney 《Topics in stroke rehabilitation》2020,27(4):241-250
ABSTRACT
Background
Post-stroke dysphagia is characterized by reduced corticolingual excitability and lingual pressure; however, it remains unknown if transcranial magnetic stimulation (TMS) directly facilitates lingual pressure generation. 相似文献43.
Alison Schinkel-Ivy Andrew H. Huntley Cynthia J. Danells Elizabeth L. Inness Avril Mansfield 《Topics in stroke rehabilitation》2020,27(4):262-271
ABSTRACT
Background
Reactive balance training (RBT) has been previously found to reduce fall risk in individuals with sub-acute stroke; however, our understanding of the effects of RBT on specific balance impairments is lacking. 相似文献44.
Karen L. Frost Gina Bertocci Craig Smalley 《Disability and rehabilitation. Assistive technology》2020,15(6):629-636
AbstractBackground: Wheelchair users (WCUs) often rely on ramps for access to transit buses. Previous studies indicate WCUs have difficulty using ramps for bus ingress/egress and many transportation-related incidents occur on ramps. However, experiences of WCU ramp usage during ingress/egress have not been fully described.Methods: Cross-sectional, internet-based survey of WCUs who ride transit buses was conducted. The participants were queried on frequency of bus usage, difficulty and incidents involving ramps, and factors contributing to difficulty and incidents. Wheelchair characteristics, primary condition, and whether participants received travel training were also captured. Chi-square was used to describe relationships between wheelchair type and frequency of difficulties and incidents, and odd ratios were used to determine likelihood of the incidents.Results: The majority (55.7%) of 384 participants reported using public transportation ≥ 1 per week. Seventy-eight percent of WCUs had ≥ 1 ramp incident over the past 3?years, with an increased likelihood of incidents occurring during ingress (OR = 1.53; CI 1.21–1.86). Of those who had an incident, 22% were injured or had damage to their wheelchair. Over 60% of those who had an incident identified steep ramp slope as being the contributing factor. Steep ramp slope, exterior ramp thresholds and wet surfaces were the most common contributing factors to difficulty using ramps.Conclusion: This is the first large-scale US study enabling WCUs to describe their experiences using transit bus ramps. Despite ADA guidelines, steep ramps remain the primary factor contributing to incidents and difficulty when using ramps to access transit buses.
- Implications for rehabilitation
The discrepancy between ADA maximum allowable ramp slopes for the built environment and transit buses may require an increased level of effort that is a barrier to transportation accessibility for some wheelchair users.
Wheelchair users who access transit buses should be made aware of, and trained, to navigate ramp configurations found in the environment.
We suggest rehabilitation therapists provide skills training specific to navigating transit bus ramp slopes that may be steeper and narrower than building ramps.
45.
R.J. van de Peppel M.T. van der Beek L.G. Visser M.G.J. de Boer J. Wallinga 《International journal of antimicrobial agents》2019,53(3):284-293
Objectives
Triazole resistance in Aspergillus spp. is emerging and complicates prophylaxis and treatment of invasive aspergillosis (IA) worldwide. New polymerase chain reaction (PCR) tests on broncho-alveolar lavage (BAL) fluid allow for detection of triazole resistance at a genetic level, which has opened up new possibilities for targeted therapy. In the absence of clinical trials, a modelling study delivers estimates of the added value of resistance detection with PCR, and which empiric therapy would be optimal when local resistance rates are known.Design
A decision-analytic modelling study was performed based on epidemiological data of IA, extended with estimated dynamics of resistance rates and treatment effectiveness. Six clinical strategies were compared that differ in use of PCR diagnostics (used vs not used) and in empiric therapeutic choice in case of unknown triazole susceptibility: voriconazole, liposomal amphotericin B (LAmB) or both. Outcome measures were proportion of correct treatment, survival and serious adverse events.Results
Implementing aspergillus PCR tests was projected to result in residual treatment-susceptibility mismatches of <5% for a triazole resistance rate up to 20% (using voriconazole). Empiric LAmB outperformed voriconazole at resistance rates >5–20%, depending on PCR use and estimated survival benefits of voriconazole over LAmB. Combination therapy of voriconazole and LAmB performed best at all resistance rates, but the advantage over the other strategies should be weighed against the expected increased number of drug-related serious adverse events. The advantage of combination therapy over LAmB monotherapy became smaller at higher triazole resistance rates.Conclusions
Introduction of current aspergillus PCR tests on BAL fluid is an effective way to increase the proportion of patients that receive targeted therapy for IA. The results indicate that close monitoring of background resistance rates and adverse drug events are important to attain the potential benefits of LAmB. The choice of strategy ultimately depends on the probability of triazole resistance, the availability of PCR and individual patient characteristics. 相似文献46.
AbstractIn light of a growing body of evidence demonstrating pervasive health disparities, medical schools are increasingly incorporating educational programs on social medicine in undergraduate and graduate medical curricula. In 2015, we significantly restructured the cultural competency instruction for medical students at our institution, focusing on achieving greater health equity through caring for vulnerable populations and acknowledging and addressing bias and stereotyping. In order to facilitate educational sustainability while students were immersed in clinical care, a key element of our approach included extending teaching into the clerkship year. The resulting longitudinal thread, Health Equity and Social Justice, empowers future physicians with the knowledge and skills to work towards greater health equity. This article discusses the lessons learned in the implementation of this novel educational program. Our approach can serve as a model for other institutions considering similar instructional reform. 相似文献
47.
48.
Amanda H. Anderson Dawei Xie Xue Wang Robin L. Baudier Paula Orlandi Lawrence J. Appel Laura M. Dember Jiang He John W. Kusek James P. Lash Sankar D. Navaneethan Akinlolu Ojo Mahboob Rahman Jason Roy Julia J. Scialla James H. Sondheimer Susan P. Steigerwalt F. Perry Wilson Raymond R. Townsend 《American journal of kidney diseases》2021,77(1):56-73.e1
49.
F. Murina R. Felice S. Di Francesco L. Nelvastellio I. Cetin 《Gynecological endocrinology》2020,36(5):431-435
AbstractThis study is a single-center, retrospective analysis of postmenopausal women presenting with dyspareunia and vulvar pain, aiming to evaluate relative effectiveness of vestibular CO2 laser therapy as a treatment. Three monthly sessions of laser were performed to each patient and thereafter a three-months follow-up was stablished. A total number of 72 patients undergoing vestibular laser treatment were recruited from patient files in the period between 2016 and 2018. Among these, 39 women also received a concomitant treatment with ospemifene (60?mg/day) during the study period. There was a statistically significant reduction of all the symptoms in both groups up to the three month follow-up. Regarding dryness and dyspareunia, the relief tent to be more prominent in the ospemifene?+?laser group at all follow-ups and remained statistically significant at three-month follow-up. Specifically, vestibular dryness was significantly lower in the ospemifene?+?laser group compared with the laser treatment group (?87% vs???34%, respectively), and the vestibular health score started declining faster in the ospemifene?+?laser group. Although, additional research is needed to understand the mechanism of action, our data shows that a combination regimen of laser and ospemifene may improve clinical effectiveness for long-term treatment of symptoms associated with the under-recognized genitourinary syndrome of menopause. 相似文献
50.
Paolo Vineis Inge Huybrechts Christopher Millett Elisabete Weiderpass 《Molecular oncology》2021,15(3):764
Intervening on risk factors for noncommunicable diseases (including cancer) in industrialized countries could achieve a reduction of between 30% and 40% of premature deaths. In the meantime, the need to intervene against the threat of climate change has become obvious. CO2 emissions must be reduced by 45% by the year 2030 and to zero by 2050 according to recent agreements. We propose an approach in which interventions are designed to prevent diseases and jointly mitigate climate change, the so‐called cobenefits. The present article describes some examples of how climate change mitigation and cancer prevention could go hand in hand: tobacco control, food production, and transportation (air pollution). Many others can be identified. The advantage of the proposed approach is that both long‐term (climate) and short‐term (health) benefits can be accrued with appropriate intersectoral policies.
Abbreviations
- GHG
- greenhouse gases
- IARC
- International Agency for Research on Cancer
- LMICs
- low‐ and middle‐income countries
- NCD
- noncommunicable disease
- PMI
- Philip Morris International
- SDGs
- Sustainable Development Goals
- UPF
- ultraprocessed food